483
Kevin B. Kim, Clinical InvestigatorKevin B. Kim, Clinical Investigator – FDA 483, Oct 16, 2013
Record Details
An FDA inspection of Kevin B. Kim, Clinical Investigator in Houston, TX, revealed significant deficiencies in clinical trial conduct. The observations included failures to obtain proper informed consent, deviations from the investigational plan, and inadequate investigational drug disposition records. These issues indicate a lack of adherence to regulatory requirements for human subject protection and clinical study management.
View Company Profile
ID · 58179df4-691f-4861-9d9b-8b7f89e06e3f
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.